SG11202109160UA - Reducing intersample analyte variability in complex biological matrices - Google Patents

Reducing intersample analyte variability in complex biological matrices

Info

Publication number
SG11202109160UA
SG11202109160UA SG11202109160UA SG11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA SG 11202109160U A SG11202109160U A SG 11202109160UA
Authority
SG
Singapore
Prior art keywords
intersample
reducing
complex biological
biological matrices
analyte variability
Prior art date
Application number
Other languages
English (en)
Inventor
Daniel Drolet
David Astling
Carlowitz Ira Von
Thomas Howard Hraha
Jan Hoh
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of SG11202109160UA publication Critical patent/SG11202109160UA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827Total protein determination, e.g. albumin in urine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/34Purifying; Cleaning
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/493Physical analysis of biological material of liquid biological material urine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/06Investigating concentration of particle suspensions
    • G01N15/075Investigating concentration of particle suspensions by optical means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
SG11202109160U 2019-03-22 2020-03-20 Reducing intersample analyte variability in complex biological matrices SG11202109160UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962822349P 2019-03-22 2019-03-22
PCT/US2020/023866 WO2020198011A1 (en) 2019-03-22 2020-03-20 Reducing intersample analyte variability in complex biological matrices

Publications (1)

Publication Number Publication Date
SG11202109160UA true SG11202109160UA (en) 2021-10-28

Family

ID=70228886

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109160U SG11202109160UA (en) 2019-03-22 2020-03-20 Reducing intersample analyte variability in complex biological matrices

Country Status (10)

Country Link
US (1) US20220178940A1 (de)
EP (1) EP3942295A1 (de)
JP (1) JP2022524975A (de)
KR (1) KR20210142694A (de)
CN (1) CN113508297A (de)
AU (1) AU2020245346A1 (de)
CA (1) CA3134336A1 (de)
IL (1) IL286495A (de)
SG (1) SG11202109160UA (de)
WO (1) WO2020198011A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4233088A4 (de) * 2020-10-20 2024-10-02 Definitek Inc Quantifizierung von zuvor nicht nachweisbaren mengen
CN112666356A (zh) * 2020-12-31 2021-04-16 国家纳米科学中心 一种检测痕量蛋白质的方法
CN116899626B (zh) * 2023-09-08 2023-12-26 北京青颜博识健康管理有限公司 一种点击化学反应的催化体系组合物及其制备方法和在生物检测中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE318832T1 (de) 1990-06-11 2006-03-15 Gilead Sciences Inc Verfahren zur vervendung von nukleinsäureliganden
US5719273A (en) 1993-06-14 1998-02-17 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide
US5945527A (en) 1996-05-30 1999-08-31 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US20100254581A1 (en) * 2009-04-07 2010-10-07 Reveal Sciences, Llc Device, method, and apparatus for biological testing with a mobile device
EP2558478B1 (de) 2010-04-12 2018-03-07 Somalogic, Inc. An 5 positionen modifizierte pyrimidine und ihre verwendung

Also Published As

Publication number Publication date
CA3134336A1 (en) 2020-10-01
AU2020245346A1 (en) 2021-09-09
IL286495A (en) 2021-10-31
US20220178940A1 (en) 2022-06-09
KR20210142694A (ko) 2021-11-25
CN113508297A (zh) 2021-10-15
WO2020198011A1 (en) 2020-10-01
JP2022524975A (ja) 2022-05-11
EP3942295A1 (de) 2022-01-26

Similar Documents

Publication Publication Date Title
IL286495A (en) Reducing inter-sample analysis variability in complex biological matrices
EP3371194A4 (de) Proteinsequenzierungsverfahren und reagenzien
SG11202105441WA (en) Direct oligonucleotide synthesis on cells and biomolecules
IL290245A (en) Single cell analysis
EP3735481A4 (de) Verfahren zur herstellung eines hochauflösenden dna-arrays und seine anwendung in der sequenzierung
IL288014A (en) Controlling inter-sample test substance variability in complex biological matrices
HK1254396A1 (zh) 一種dna片段體外組裝方法和試劑盒
IL279921A (en) A system and method of evaluating and determining color in gemstones
GB201813449D0 (en) Skin cell analysis
EP3815094A4 (de) Nukleinsäureumordnung und integrationsanalyse
EP3880151A4 (de) Bestimmung der behandlungsreaktion in einzelnen zellen
IL261835A (en) Analytical methods and arrays for their use
GB201913908D0 (en) Improvements in interaction analysis
SG11202108157WA (en) Biological analysis system and methods
SG11202102265UA (en) Hemoglobin assay reagent, assay kit and assay method
IL281796A (en) Quantification of antibody in biological samples
SG11202110398QA (en) Concurrent analysis of multiple analytes
EP3891301A4 (de) Quantifizierung von fremd-dna in blutproben mit niedrigem volumen mittels snp-profilierung
EP3610012A4 (de) Hochdurchsatz-absorptionsmessungen von proben in mikrokapillaranordnungen
IL278937A (en) HSP70 protein levels in PBMC samples as a disease biomarker
EP3814500A4 (de) Verfahren zur analyse von dna in urin
GB201710524D0 (en) Controlling intersample analyte variability in complex biological matrices
IL287077A (en) Methods and systems for scanning using a microcapillary array
IL286419A (en) A cell line containing a new form of selection marker and using them to make proteins
GB201918900D0 (en) Improvements in or relating to assay timing